AVTX Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (11 июнь 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 50 028 950.12% compare to its pairs and should correct upwards.

Stats
Объем за сегодня	7 961
Средний объем	674 911
Рыночная капитализация	11.39M
EPS	$-141.14 ( Q1 \| 2024-05-13 )
Дата следующего отчета о доходах	( $-0.190 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.220 (Sector) 42.63 (Industry) 24.32
ATR14	$0.169 (1.53%)

AADI -0.57%

ABCL -2.28%

ABCM 0.04%

ABEO -0.22%

ABIO 2.50%

ABOS 1.15%

ABSI -0.22%

ABUS 1.27%

ABVX -1.19%

ACAD 1.01%

ACER -17.95%

ACET -1.53%

ACGN 1.29%

ACHL 1.41%

ACHV -1.68%

ACIU -0.67%

ACLX -0.24%

ACRV -2.12%

ACST -2.17%

ACXP 6.25%

ADAG 3.17%

ADAP 0.00%

ADGI 0.87%

ADIL 3.05%

ADMA 0.19%

ADPT -1.15%

ADTX -2.05%

ADVM -2.53%

ADXN -3.80%

AEON -1.33%

AEZS -5.62%

AFMD 6.70%

AGEN -2.27%

AGIO 0.61%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 50.66%

AKBA 1.83%

AKRO 1.91%

AKTX 28.16%

AKUS 0.00%

ALBO 0.00%

ALDX -2.58%

ALEC 0.00%

ALGS -3.50%

ALKS 2.48%

ALLK -1.53%

ALLO 4.51%

ALLR -7.57%

ALNA 3.16%

ALNY 1.93%

ALPN 0.00%

ALPX 0.00%

ALRN 1.57%

ALT 3.51%

ALVR 8.21%

ALXN 0.00%

ALXO -1.27%

ALZN -3.78%

AMRN 22.61%

AMTI -3.13%

ANAB 0.17%

ANEB 1.00%

ANGN 0.00%

ANIX -1.87%

ANL -11.73%

ANNX -4.55%

ANPC -3.15%

APGE -1.57%

APGN 8.48%

APGNW 30.65%

APLM -1.91%

APLS 2.52%

APLT -0.78%

APM -0.44%

APOP 0.38%

APRE 1.13%

APTO -3.30%

APTX 3.17%

APVO 0.96%

ARAV -13.39%

ARCT 1.47%

ARDS -5.14%

ARDX 2.63%

ARGX -0.66%

ARNA 0.00%

ARPO -0.90%

ARQT 3.18%

ARTL 1.85%

ARTLW 0.00%

ARVN -2.59%

ARWR 0.53%

ASLN -2.29%

ASMB 1.45%

ASND 0.34%

ATAI -5.71%

ATHA 0.00%

ATHE -1.55%

ATHX -33.50%

ATNF -1.90%

ATOS 3.33%

ATRA 7.68%

ATXI 0.00%

ATXS -0.66%

AUPH 2.78%

AURA -1.38%

AUTL 6.42%

AVBP 0.75%

AVEO 0.00%

AVIR 3.43%

AVRO 0.68%

AVTE 1.78%

AVTX 0.87%

AVXL -2.37%

AXLA 0.00%

AXSM -1.02%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -1.26%

BCAB 8.03%

BCDA 6.12%

BCDAW 73.91%

BCEL 2.41%

BCLI 1.15%

BCRX -0.61%

BCTX -3.60%

BCTXW -9.76%

BCYC 2.63%

BDRX -2.06%

BDTX 19.37%

BEAM 1.89%

BFRA -2.91%

BGNE 1.61%

BIOR -4.01%

BIVI 3.73%

BLCM -6.68%

BLI -5.88%

BLPH 8.33%

BLRX 2.29%

BLTE -0.49%

BLU 0.03%

BLUE 5.85%

BMEA 2.78%

BMRN 1.12%

BNOX -1.80%

BNTC 1.21%

BNTX 0.84%

BOLD -1.81%

BOLT 1.17%

BPMC 1.31%

BPTH -3.46%

BPTS -13.47%

BRNS -4.95%

BRTX 0.00%

BTAI -0.69%

BTTX -5.21%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -2.07%

CABA 0.73%

CADL 7.40%

CALA 0.00%

CALC 3.36%

CALT -2.47%

CAPR 2.59%

CARA -1.47%

CARM -6.77%

CASI 4.46%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -2.61%

CCCC 0.83%

CCXI 0.00%

CDAK 0.00%

CDIO -4.35%

CDIOW 27.93%

CDMO -0.87%

CDMOP 0.04%

CDT -1.09%

CDTTW 40.35%

CDTX 0.89%

CDXC 0.00%

CDXS 1.22%

CELC 3.02%

CELU 2.77%

CELUW -16.67%

CERC -1.68%

CERE 0.02%

CERO -0.67%

CEROW -7.32%

CFRX -27.95%

CGEM 1.22%

CGEN 0.00%

CGON -0.06%

CGTX 4.55%

CHMA -6.00%

CHRS -0.57%

CINC 0.00%

CING 1.98%

CINGW -50.00%

CKPT 0.52%

CLBS -16.75%

CLDX 2.68%

CLGN -0.95%

CLLS -3.50%

CLNN -4.07%

CLNNW 40.00%

CLRB -0.61%

CLSD 4.17%

CLSN -0.68%

CLVS 0.00%

CMMB 0.03%

CMND 0.00%

CMPI 0.00%

CMPX 0.83%

CMRA 8.70%

CMRAW 0.00%

CMRX 0.00%

CNCE 0.00%

CNSP -5.48%

CNST 0.00%

CNTA 2.75%

CNTB -4.69%

CNTX 6.22%

COCP 7.51%

COEPW 0.50%

COGT 2.56%

CORT 2.69%

COYA 12.68%

CPRX -0.45%

CRBP 14.68%

CRBU 3.19%

CRDF 0.00%

CRGX 1.28%

CRIS 7.38%

CRNX -0.42%

CRSP 3.87%

CRTX 2.63%

CRVO 0.87%

CRVS 1.90%

CSBR 7.08%

CTCX -10.60%

CTIC 0.06%

CTMX -8.59%

CTNM -10.99%

CTXR 4.00%

CUE 2.08%

CVAC -7.41%

CVKD 6.41%

CWBR -2.52%

CYAD -12.96%

CYCC -1.60%

CYCCP -3.75%

CYCN -0.87%

CYT -2.27%

CYTK -1.61%

CYTO -3.68%

DARE -3.44%

DAWN 0.40%

DBTX -0.81%

DBVT -2.88%

DFFN 10.28%

DICE 0.06%

DMAC 0.38%

DNLI 2.76%

DNTH 11.62%

DOMH 3.81%

DRMA 1.79%

DRMAW -12.50%

DRNA 0.00%

DRTS -1.69%

DRTSW 0.00%

DRUG -4.42%

DSGN 6.05%

DTIL -1.64%

DYAI 6.19%

EARS -1.77%

EDIT 2.07%

EDSA 0.00%

EFTR 0.77%

EFTRW -48.48%

EIGR 0.00%

ELAB -0.26%

ELDN 1.05%

ELEV -3.94%

ELOX -6.84%

ELTX 1.88%

ELVN -2.61%

ELYM -4.27%

ENGN 10.49%

ENGNW 5.30%

ENLV 4.41%

ENOB 1.79%

ENSC -1.82%

ENTA 5.09%

ENTO -6.78%

ENTX 2.45%

ENVB 0.26%

EPIX 0.74%

EPRX 4.81%

EPZM 0.00%

EQ 2.83%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.32%

ERNA 4.64%

ERYP 1.30%

ESLA -1.33%

ESLAW -0.28%

ETNB 2.48%

ETON 0.56%

ETTX 0.00%

EVAX -7.76%

EVGN -4.23%

EVLO 0.00%

EWTX -0.18%

EXAI 4.52%

EXEL -0.45%

EYEG 0.40%

EYEN -8.35%

EYPT 3.74%

FATE 0.78%

FBIO 0.51%

FBIOP 0.76%

FBLG -10.10%

FBRX 5.45%

FDMT 3.19%

FENC 2.11%

FGEN 0.00%

FHTX 2.41%

FIXX 0.77%

FMTX 0.00%

FNCH 2.96%

FOLD 3.48%

FREQ 4.76%

FRLN 0.15%

FRTX 3.58%

FSTX 0.00%

FTRE -0.51%

FULC -9.31%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -3.32%

GANX 16.27%

GBIO 4.35%

GBT 0.01%

GDTC 3.00%

GERN 0.99%

GHRS -0.08%

GLMD -0.51%

GLPG -0.80%

GLSI -4.19%

GLTO -1.57%

GLUE 6.47%

GLYC 2.97%

GMAB -2.15%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT -7.35%

GNLX 2.93%

GNPX 4.12%

GNTA 0.00%

GOSS -0.89%

GOVX 0.00%

GOVXW 5.06%

GPCR -5.42%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 8.09%

GRTX 0.81%

GTHX -2.05%

GUTS -14.15%

GXGXW 41.67%

GYRE -3.83%

HALO -2.42%

HARP 0.09%

HCWB 5.94%

HEPA 7.27%

HGEN -84.62%

HILS 5.66%

HLVX 5.43%

HOOK 2.13%

HOTH -1.20%

HOWL -1.54%

HRMY -0.77%

HRTX -1.36%

HSTO 0.00%

HUMA -2.92%

HUMAW -13.67%

IBRX -4.49%

ICCC 0.82%

ICPT 0.21%

ICU -0.71%

ICUCW 24.73%

ICVX -0.91%

IDRA -23.04%

IDYA -1.96%

IFRX -1.27%

IGMS 4.02%

IKNA 2.26%

IKT 1.59%

IMAB 0.27%

IMCR 1.63%

IMGN 0.02%

IMGO 0.00%

IMMP 2.65%

IMMX -1.45%

IMNM -2.18%

IMNN 11.30%

IMPL -27.27%

IMRA 15.96%

IMRN 1.35%

IMRX 13.42%

IMTX 2.95%

IMTXW 7.91%

IMUX 3.25%

IMV 0.00%

IMVT -1.22%

INAB 6.87%

INBX 1.51%

INCY 0.13%

INDP 2.05%

INFI -52.38%

INKT 3.99%

INM -3.63%

INMB -2.41%

INO -0.10%

INSM 3.29%

INTS 3.97%

INVA -0.25%

INZY -1.05%

IOBT 6.45%

IONS -0.25%

IOVA 7.01%

IPA -0.96%

IPHA -2.12%

IPSC -2.99%

IRON -1.49%

ISEE 0.38%

ITOS -1.57%

ITRM -10.61%

IVA 0.16%

IVVD -3.57%

JAGX -8.35%

JANX -3.09%

JAZZ 1.32%

JNCE 0.00%

JSPR 0.17%

JSPRW 6.06%

JUNS 0.00%

JUNSW 0%

KA -1.46%

KALV 1.16%

KDNY 0.22%

KMPH -0.34%

KNSA -2.39%

KNTE -0.38%

KOD 1.44%

KPRX 14.00%

KPTI 4.47%

KRBP 16.67%

KRON 20.93%

KROS -2.03%

KRRO -10.21%

KRTX 0.03%

KRYS 0.37%

KTRA -9.52%

KTTA -0.54%

KTTAW 0.00%

KURA 2.87%

KYMR 0.90%

KYTX -3.33%

KZIA -1.84%

KZR -1.52%

LABP 0.57%

LBPH 5.38%

LBPS 0.00%

LBPSW 14.81%

LEGN -2.83%

LENZ 6.63%

LEXX -6.12%

LEXXW -8.05%

LGND 0.72%

LGNDV 0.00%

LGVN -22.64%

LIAN 0.00%

LIFE 2.70%

LIPO 2.76%

LIXT -0.41%

LIXTW 16.95%

LJPC -0.32%

LMNL 0.12%

LOGC -0.54%

LPCN -2.01%

LPTX -1.75%

LQDA -0.29%

LRMR -2.91%

LSTA 6.38%

LTRN 3.52%

LUMO 5.81%

LVTX 3.56%

LXEO -6.14%

LXRX 1.58%

LYEL 6.36%

LYRA -0.67%

MACK 0.00%

MBIO 9.73%

MBRX -0.46%

MCRB 7.38%

MDGL 14.56%

MDNA -13.16%

MDWD -0.67%

MDXG -0.14%

MEIP -1.40%

MESO 1.53%

MGNX 7.64%

MGTA -7.74%

MGTX 0.21%

MGX -0.47%

MIRM 2.54%

MIRO 0.59%

MIST -1.37%

MITO 0.00%

MLEC -0.92%

MLECW 0.00%

MLND -5.36%

MLTX 3.48%

MLYS -3.78%

MNKD 3.56%

MNMD -4.32%

MNOV 0.75%

MNPR 6.09%

MOLN 22.60%

MOR -0.16%

MORF -3.59%

MREO 1.44%

MRKR 11.24%

MRNA -0.13%

MRNS 1.30%

MRSN 1.80%

MRTX -0.17%

MRUS 7.09%

MRVI -3.80%

MTCR -1.29%

MTEM -5.13%

MTP -18.50%

MURA 0.60%

MYMD -5.39%

NAMS 0.91%

NAMSW 12.08%

NAUT 1.53%

NBRV 0.71%

NBSE -1.56%

NBTX 2.84%

NCNA -5.85%

NERV 1.27%

NEXI 5.86%

NGM -1.28%

NGNE -0.46%

NKGN -1.40%

NKGNW -6.98%

NKTR 4.56%

NKTX -1.66%

NLSP 6.33%

NLSPW -41.53%

NMRA -5.09%

NMTR -42.97%

NOVN -24.84%

NRBO 3.08%

NRIX 5.42%

NRSN -3.81%

NRSNW 11.11%

NRXP 4.40%

NRXPW -16.08%

NRXS 2.05%

NTBL 7.43%

NTEC -12.45%

NTHI 0%

NTLA 2.02%

NTRBW 2.15%

NUVL -1.26%

NVAX 4.50%

NVCT 1.53%

NVIV -34.28%

NXTC 3.65%

NYMX -0.05%

OABI -2.39%

OABIW 5.59%

OBIO -0.38%

OBSV 0.00%

OCEA 2.56%

OCGN -1.61%

OCS 0.93%

OCUL 0.80%

OCUP 0.88%

ODT -4.27%

OKYO 3.90%

OLMA 0.44%

OMER -1.04%

OMGA 0.94%

ONCO -2.57%

ONCR -3.08%

ONCS 31.87%

ONCT 1.09%

ONCY 1.96%

ONTX -0.47%

ONVO -1.07%

OPNT 0.00%

OPT -3.10%

ORGS 7.93%

ORIC -6.86%

ORMP -2.82%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 7.92%

OVID 0.32%

OYST 0.00%

PALI -2.60%

PASG 0.00%

PBLA 6.67%

PBM 0.00%

PBYI -0.57%

PCSA 13.92%

PCVX 0.97%

PDSB -2.13%

PEPG 0.22%

PGEN -3.53%

PHAR 4.02%

PHAS 0.00%

PHAT 2.70%

PHIO 0.42%

PHIOW 36.47%

PHVS -0.75%

PHXM -5.20%

PIRS 3.87%

PKBO 0.00%

PKBOW 0.00%

PLRX -1.91%

PLUR 2.18%

PMN -4.47%

PMVP 1.76%

PNT 0.16%

PPBT 4.17%

PRAX -2.86%

PRDS 0.93%

PRLD 1.52%

PROG -3.47%

PROK -19.87%

PRQR 1.11%

PRTA -2.61%

PRTC 4.56%

PRTG 4.55%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.81%

PSTX 3.97%

PTCT 0.21%

PTE -0.82%

PTGX 2.35%

PTIXW 143.75%

PULM -1.74%

PXMD -0.68%

PYPD 2.11%

PYXS -1.13%

QLGN 4.17%

QNCX 3.66%

QNRX -2.13%

QSI 0.69%

QSIAW 0.00%

QTTB -3.25%

QURE -2.79%

RAIN -1.63%

RANI -3.37%

RAPT -3.40%

RARE -1.36%

RCKT 2.51%

REGN 0.88%

RENB -2.01%

REPL 0.00%

RETA 0.02%

REUN -0.89%

REVB 7.66%

REVBU 3.46%

REVBW 3.91%

RGLS -1.43%

RGNX -0.95%

RIGL 0.00%

RLAY -3.98%

RLMD -2.56%

RLYB 7.54%

RNA 6.68%

RNAC -5.13%

RNAZ 3.10%

RNXT 2.94%

ROIV -0.09%

ROIVW 4.56%

RPHM 1.79%

RPRX 0.11%

RPTX -5.00%

RUBY 2.70%

RVLP -32.05%

RVMD -2.11%

RVMDW 41.23%

RVNC 7.30%

RVPH 2.76%

RVPHW 52.94%

RXDX 0.09%

RXRX -0.46%

RYTM -2.17%

RYZB 0.02%

RZLT -1.84%

SABS 2.11%

SABSW 89.00%

SAGE -2.75%

SANA -0.43%

SAVA -1.67%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -4.17%

SCPH -0.24%

SCPS 0.00%

SEEL -1.92%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 5.14%

SGMT 1.64%

SGTX -2.56%

SIOX 22.63%

SLDB -3.96%

SLGL -1.45%

SLN 0.29%

SLNO -1.34%

SLRX 3.04%

SLS 0.71%

SMMT -5.51%

SNDX -2.03%

SNGX -1.75%

SNPX 0.96%

SONN -3.61%

SPPI -0.49%

SPRB -1.52%

SPRC -0.87%

SPRO 3.85%

SRNE -22.03%

SRPT -0.99%

SRRA 0.00%

SRRK 0.73%

SRZN 1.61%

STAB 0.00%

STOK 6.38%

STRO -0.78%

STSA 0.00%

STTK 0.60%

SURF -0.93%

SVRA -1.44%

SWTX -2.63%

SYBX 3.18%

SYRS 2.54%

TALS -0.73%

TARA 2.24%

TARS 0.56%

TBPH 1.38%

TCBP -0.94%

TCDA 0.00%

TCON -0.92%

TCRR 0.00%

TCRT 3.85%

TCRX -2.30%

TECH -0.27%

TENX -1.44%

TERN 4.86%

TFFP 5.41%

TGTX 1.57%

THRX 0.12%

TIL 3.53%

TLC 0.00%

TLSA 1.02%

TNGX -3.35%

TNXP -3.62%

TNYA -1.86%

TPST -1.89%

TRDA -0.13%

TRVI 2.77%

TRVN 0.93%

TSHA -4.34%

TSVT 0.00%

TTNP 7.60%

TVTX -2.75%

TYRA 1.10%

UBX 0.31%

UNCY 2.57%

URGN 2.51%

UTHR 0.19%

VACC 11.36%

VALN 2.65%

VAXX 10.75%

VBIV 4.27%

VBLT -8.77%

VCEL -0.51%

VCNX 3.14%

VCYT 1.96%

VERA -1.41%

VERU 3.06%

VERV -0.56%

VIGL 4.09%

VINC 2.98%

VIR -5.22%

VIRI 3.66%

VIRX 6.00%

VKTX -6.47%

VLON -13.04%

VNDA 0.17%

VOR -3.85%

VRCA 4.32%

VRDN 10.15%

VRNA 5.69%

VRPX -0.13%

VRTX -0.36%

VSTM 4.52%

VTGN 2.45%

VTVT 0.50%

VTYX -6.98%

VXRT -3.26%

VYGR -1.14%

VYNE 0.44%

VYNT 7.78%

WINT -7.03%

WVE 5.08%

XBIO 1.34%

XBIT -0.60%

XCUR 1.69%

XENE -0.73%

XERS -0.86%

XFOR 0.96%

XLO 5.66%

XLRN 0.00%

XNCR 0.23%

XOMA 3.05%

XOMAO -0.39%

XOMAP 0.24%

XRTX -1.83%

YMAB -0.50%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.20%

ZNTL -4.40%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Truex Samantha	Buy	0
2024-03-27	Goldman Jonathan	Buy	0
2024-03-28	Kantoff Aaron	Buy	0
2023-12-20	Persson Magnus	Buy	3 334	Stock Option (Right to Buy)
2023-12-20	Almenoff June Sherie	Buy	3 334	Stock Option (Right to Buy)

INSIDER POWER
-64.98
Last 97 transactions
Buy: 5 555 925 \| Sell: 5 291 542

Корреляция (AI algo v.1.1b): Undervalued: 50 028 950.12% $5 510 700 paired level. (Алгоритм отслеживает изменения наиболее коррелирующих акций в режиме реального времени и дает мгновенное обновление)

Объем Корреляция

Длинно: -0.18 (neutral)

Кратко: -0.78 (moderate negative)

Signal:(49.223) Neutral

Avalo Therapeutics, Inc. Корреляция

10 Самые положительные корреляции
RFAIU	0.931
BOTT	0.819

10 Самые отрицательные корреляции
OZEM	-1
EIOMX	-0.917
KMDNX	-0.917
NICHX	-0.891
CCLFX	-0.869
AMCLX	-0.81

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Avalo Therapeutics, Inc. Корреляция - Валюта/Сырье

-0.40
( neutral )

-0.44
( neutral )

0.22
( neutral )

0.00
( neutral )

0.33
( neutral )

-0.61
( weak negative )

Avalo Therapeutics, Inc. Финансовые показатели

Annual	2023
Выручка:	$1.92M
Валовая прибыль:	$640 000 (33.26 %)
EPS:	$-113.58

FY	2023
Выручка:	$1.92M
Валовая прибыль:	$640 000 (33.26 %)
EPS:	$-113.58

FY	2022
Выручка:	$18.05M
Валовая прибыль:	$14.62M (80.98 %)
EPS:	$-1 062.68

FY	2021
Выручка:	$5.40M
Валовая прибыль:	$3.91M (72.38 %)
EPS:	$-9.96

Financial Reports:

No articles found.

Avalo Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe Crohn\'s disease, and ulcerative colitis; and Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still\'s disease, including adult-onset still\'s disease and systemic juvenile idiopathic arthritis. Its products for rare genetic diseases in Phase III clinical trials include AVTX-801, a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, a L-fucose substrate replacement therapy for the treatment of LADII, also known as SLC35C1-CDG. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.